Wang; Hsin-Ell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Hsin-Ell.The latest application filed is for "targeted prodrug enzyme fusion carrier and application thereof".

Company Profile

3.6.9

Wang; Hsin-Ell - Taipei TW
Wang; Hsin-Ell - Taipei City TW
Wang; Hsin-Ell - Taoyuan County TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeted prodrug cytosine deaminase fusion carrier and application thereof Grant 10,947,270 - Chang , et al. March 16, 2	2021-03-16
Targeted Prodrug Enzyme Fusion Carrier And Application Thereof App 20190211057 - Chang; C. Allen ; et al.	2019-07-11
Dual targeting drug carrier and application thereof Grant 10,202,432 - Chang , et al. Feb	2019-02-12
Radiolabeled active targeting pharmaceutical composition and the use thereof Grant 10,117,956 - Wang , et al. November 6, 2	2018-11-06
Radiolabeled Active Targeting Pharmaceutical Composition And The Use Thereof App 20180117188 - WANG; Hsin-Ell ; et al.	2018-05-03
Radiolabeled active targeting pharmaceutical composition and the use thereof Grant 9,789,214 - Wang , et al. October 17, 2	2017-10-17
Dual Targeting Drug Carrier And Application Thereof App 20170058011 - CHANG; Cheng Allen ; et al.	2017-03-02
Radiolabeled Active Targeting Pharmaceutical Composition And The Use Thereof App 20150231285 - WANG; Hsin-Ell ; et al.	2015-08-20
18F-labeled monomeric galactose derivative used as tomography probe Grant 8,961,931 - Duh , et al. February 24, 2	2015-02-24
Radiolabeled Nucleoside Analogue, And Preparation Method And Use Thereof App 20140221639 - WANG; HSIN-ELL ; et al.	2014-08-07
18F-Labeled Monomeric Galactose Derivative Used as Tomography Probe App 20120259102 - Duh; Ting-Shien ; et al.	2012-10-11
Radiolabeled Nucleoside Analogue, And Preparation Method And Use Thereof App 20120178919 - WANG; HSIN-ELL ; et al.	2012-07-12
Liposome Compositions Useful For Tumor Imaging And Treatment App 20090081121 - Ting; Gann ; et al.	2009-03-26
Nuclear molecular imaging contrast agent App 20070154390 - Liang; Huang Chien ; et al.	2007-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.